Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/New Haven
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in New Haven, CT

Studies commonly pay $75 to $4,500 per completed study

1,187 clinical trials are currently recruiting participants within 30 miles of New Haven. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,187studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near New Haven right now

Top 25 of 1,187 recruiting studies, sorted by proximity — each links to its official registry page

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Yale-New Haven Hospital North Haven Medical Center — New Haven, Connecticut (0.3 mi) · Sponsor: Abramson Cancer Center at Penn Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06551116)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Yale-New Haven Hospital-Yale Cancer Center — New Haven, Connecticut (0.3 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought
Clinical Research Site — Cromwell, Connecticut (24.4 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07398417)

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study, Healthy Adults Phase 1 Interventional 139 participants sought
Pfizer Clinical Research Unit - New Haven — New Haven, Connecticut (0.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07660731)

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Ovarian Cancer Recurrent Phase 1, Phase 2 Interventional 460 participants sought
Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0019) — New Haven, Connecticut (0.3 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06843447)

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer, Locally Advanced Phase 1, Phase 2 Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — New Haven, Connecticut (0.3 mi) · Sponsor: Avenzo Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07038343)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Waterbury, Connecticut (18.3 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Ulcerative Colitis, Crohn's Disease Phase 3 Interventional 240 participants sought
Stony Brook University Medical Center — Stony Brook, New York (28.9 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05442567)

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA) Phase 3 Interventional 400 participants sought
Chase Medical Research LLC — Hamden, Connecticut (6.0 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07481630)

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck Phase 1 Interventional 1,006 participants sought
North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists — Port Jefferson Station, New York (27.4 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04389632)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Smilow Cancer Center/Yale-New Haven Hospital — New Haven, Connecticut (0.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Amyloidosis, Amyloid Cardiomyopathy Phase 3 Interventional 587 participants sought
Yale University School of Medicine - Section of Cardiology — New Haven, Connecticut (0.3 mi) · Sponsor: Eidos Therapeutics, a BridgeBio company
See eligibility & contact on ClinicalTrials.gov (NCT06563895)

Comparison of Uncomplicated Candidemia Therapy Duration in Children

Invasive Candidiasis N/A Interventional 420 participants sought
Yale New Haven Children's Hospital — New Haven, Connecticut (0.3 mi) · Sponsor: Arkansas Children's Hospital Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT05763251)

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Relapsed Refractory Multiple Myeloma Phase 3 Interventional 508 participants sought
Research Site — New Haven, Connecticut (0.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07391657)

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Coronary Artery Disease, Heart Failure Systolic N/A Interventional 754 participants sought
Yale University — New Haven, Connecticut (0.3 mi) · Sponsor: Sunnybrook Health Sciences Centre
See eligibility & contact on ClinicalTrials.gov (NCT05427370)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Polymyositis, Dermatomyositis Phase 3 Interventional 240 participants sought
Research Site — New Haven, Connecticut (0.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06455449)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis, Ulcerative Colitis Chronic Phase 2 Interventional 140 participants sought
Medical Research Center of Connecticut, LLC — Hamden, Connecticut (6.0 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06598943)

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Barrett Esophagus, Barretts Esophagus With Dysplasia N/A Interventional 2,298 participants sought
Connecticut Clinical Research Institute — Bristol, Connecticut (24.9 mi) · Sponsor: University of Colorado, Denver
See eligibility & contact on ClinicalTrials.gov (NCT05530343)

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous Gamma-Delta T-Cell Lymphoma Phase 1, Phase 2 Interventional 200 participants sought
Dren Investigational Site — New Haven, Connecticut (0.3 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT05475925)
Google-rated

Top-rated research centers in New Haven

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Yale Center for Clinical Investigation

2 Church St S #401, New Haven, CT 06519
(203) 785-3482

Pfizer New Haven Clinical Research Unit

★ 4.2
1 Howe St, New Haven, CT 06511
(800) 254-6398
"I had been doing studies here for some years and had a really bad experience with a doctor during screening. I think the dr was racist i don’t know b…"
— aster390, 1★

Center for Outcomes Research and Evaluation

★ 5.0
195 Church St 5th Floor, New Haven, CT 06510
(203) 497-1239

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Yale Interventional Oncology Research Lab

333 Cedar St, New Haven, CT 06510

Alzheimer’s Disease Research Unit

★ 5.0
1 Church St, New Haven, CT 06510
(203) 764-8100

MSU Multi-modal Imaging, Neuroinformatics, & Data Science (MINDS) Laboratory

Magnetic Resonance Research Center, 300 Cedar St, New Haven, CT 06519

Yale OCD Research Clinic

34 Park St, New Haven, CT 06510
(203) 974-7523

Medical Research Center of Connecticut

2200 Whitney Avenue Hamden Wallingford, Hamden, CT 06518
(203) 281-5161

Clinical trials in New Haven: what's recruiting

The New Haven area currently has 1,187 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to New Haven, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular4 studies
  • Immune & Skin4 studies
  • Diabetes & Metabolism2 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from New Haven, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in New Haven

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

New Haven participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in New Haven?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in New Haven safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in New Haven?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of New Haven.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in New Haven typically complete one or two studies per year.

Paid clinical trials near New Haven

Other metros within reach

Waterbury, CT1,146 Bridgeport, CT1,460 Hartford, CT445 Danbury, CT1,164 Norwich, CT121 Springfield, MA325 Yonkers, NY4,130 Queens, NY4,142

More of CT

Bridgeport1,460 Danbury1,164 Waterbury1,146 Hartford445 Norwich121

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts